BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Björnsson ES. Liver injury associated with the analgetic drug metamizole. Br J Clin Pharmacol 2020;86:1248-50. [PMID: 32400058 DOI: 10.1111/bcp.14294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Dai XL, Zhou XJ, Gu BH, Yang ZH, Lai J. Metamizole-induced acute liver failure in a boy. Clin Res Hepatol Gastroenterol 2021;45:101570. [PMID: 33303406 DOI: 10.1016/j.clinre.2020.11.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Hedenmalm K, Pacurariu A, Slattery J, Kurz X, Candore G, Flynn R. Is There an Increased Risk of Hepatotoxicity with Metamizole? A Comparative Cohort Study in Incident Users. Drug Saf 2021;44:973-85. [PMID: 34273099 DOI: 10.1007/s40264-021-01087-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Björnsson ES. Liver injury associated with the analgetic drug metamizole. Br J Clin Pharmacol 2020;86:1248-50. [PMID: 32400058 DOI: 10.1111/bcp.14294] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
4 Weber S, Benesic A, Neumann J, Gerbes AL. Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event. Drug Saf 2021;44:669-80. [PMID: 33638811 DOI: 10.1007/s40264-021-01049-z] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Clinton JW, Kiparizoska S, Aggarwal S, Woo S, Davis W, Lewis JH. Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature. Drug Saf 2021;44:1125-49. [PMID: 34533782 DOI: 10.1007/s40264-021-01109-4] [Reference Citation Analysis]
6 Weber S, Benesic A, Gerbes AL. Further evidence for the hepatotoxic potential of metamizole. Br J Clin Pharmacol 2021;87:1587-8. [PMID: 32696537 DOI: 10.1111/bcp.14473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 White CM, Browne T, Nafziger AN. Inherent Dangers of Using Non-US Food and Drug Administration-Approved Substances of Abuse. J Clin Pharmacol 2021;61 Suppl 2:S129-41. [PMID: 34396559 DOI: 10.1002/jcph.1860] [Reference Citation Analysis]